Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis

PHASE2CompletedINTERVENTIONAL

Enrollment

202

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

September 21, 2024

Study Completion Date

September 21, 2024

Conditions

Strongyloides Stercoralis InfectionStrongyloidiasis

Interventions

DRUG

Emodepside

5 mg tablets of emodepside and matching placebo tablets, 3mg ivermectin

Trial Locations (1)

Lao Tropical and Public Health Institute, Vientiane

All Listed Sponsors

collaborator

National Institute of Public Health, Vientiane, Laos

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER

NCT06373835 - Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis | Biotech Hunter | Biotech Hunter